Skip to content

Drug interactions

Ergoloid mesylates + Rizatriptan

Severity: Contraindicated

Ergoloid mesylates and Rizatriptan: contraindicated interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rizatriptan constricts cranial and other vessels, and ergoloid has some ergot-derived receptor activity, so additive vasoconstriction is possible. The vasoconstrictor effect of ergoloid is weak, but the class warning still applies.

What this interaction means in plain words

Ergoloid mesylates and Rizatriptan are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Evidence level: Low

Why it happens

Additive vasoconstriction through serotonin receptor agonism and ergot-derived receptor effects.

What to do

Avoid combining and separate by at least 24 hours. Review whether ergoloid therapy is needed.

What to ask your pharmacist

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ergoloid mesylates and Rizatriptan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ergoloid mesylates with Rizatriptan?

MediHelp rates the interaction as contraindicated. Ergoloid mesylates and Rizatriptan are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Rizatriptan constricts cranial and other vessels, and ergoloid has some ergot-derived receptor activity, so additive vasoconstriction is possible. The vasoconstrictor effect of ergoloid is weak, but the class warning still applies.

How serious is the interaction between Ergoloid mesylates and Rizatriptan?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining and separate by at least 24 hours. Review whether ergoloid therapy is needed.

What other medicines interact with Rizatriptan?

MediHelp also lists interactions of Rizatriptan with, for example, Almotriptan, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Rizatriptan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in